In late October 2022, the FDA declared a shortage of albuterol sulfate inhalation solution 0.5%, and as of early April the shortage is still in effect, according to the administration’s website.
This dosage of albuterol, which is usually found in hospitals, is the only dosage currently in shortage; patients who use albuterol inhalers are not affected by this shortage, according to tweets from the FDA.
